ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of Urate Elevation in Parkinson's Disease

ClinicalTrials.gov ID: NCT00833690

Public ClinicalTrials.gov record NCT00833690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease

Study identification

NCT ID
NCT00833690
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
The Parkinson Study Group
Network
Enrollment
75 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • inosine Drug

Drug

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Jun 4, 2014

2009 – 2012

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
University of Southern California Los Angeles California 90083
Eastern Connecticut Neurology Specialists, LLC Manchester Connecticut 06040
Institute for Neurodegenerative Disorders New Haven Connecticut 06510
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Rush University Medical Center Chicago Illinois 60612
Ochsner Clinic Foundation New Orleans Louisiana 70121
Massachusetts General Hospital Boston Massachusetts 02114
Boston University Medical Center Boston Massachusetts 02118
Michigan State University East Lansing Michigan 48824
Struthers Parkinson's Center Golden Valley Minnesota 55427
Duke University School of Medicine Durham North Carolina 27705
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44195
Oregon Health and Science University Portland Oregon 97239
Butler Hospital Movement Disorder Program Providence Rhode Island 02906
Scott & White Hospital Temple Texas 76508

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00833690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2014 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00833690 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →